These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15860370)

  • 1. Stimulants and the developing brain.
    Andersen SL
    Trends Pharmacol Sci; 2005 May; 26(5):237-43. PubMed ID: 15860370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulant medications.
    Greenhill LL; Halperin JM; Abikoff H
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):503-12. PubMed ID: 10230181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of stimulant medication in attention-deficit hyperactivity disorder.
    Poulton A
    Expert Rev Neurother; 2006 Apr; 6(4):551-61. PubMed ID: 16623654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.
    Staller JA; Faraone SV
    Expert Rev Neurother; 2007 Apr; 7(4):351-62. PubMed ID: 17425490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder.
    Ashton H; Gallagher P; Moore B
    J Psychopharmacol; 2006 Sep; 20(5):602-10. PubMed ID: 16478756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
    Golubchik P; Sever J; Weizman A
    Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of stimulants on a clinical measure of attention in children with ADHD.
    Gardner BK; Sheppard DM; Efron D
    Child Neuropsychol; 2008 Mar; 14(2):171-86. PubMed ID: 17852126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder.
    Fone KC; Nutt DJ
    Curr Opin Pharmacol; 2005 Feb; 5(1):87-93. PubMed ID: 15661631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurological basis of attention deficit hyperactivity disorder.
    Ballard S; Bolan M; Burton M; Snyder S; Pasterczyk-Seabolt C; Martin D
    Adolescence; 1997; 32(128):855-62. PubMed ID: 9426808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac safety of central nervous system stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Winterstein AG; Gerhard T; Shuster J; Johnson M; Zito JM; Saidi A
    Pediatrics; 2007 Dec; 120(6):e1494-501. PubMed ID: 18055666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of stimulant medications on the brain: possible relevance to the treatment of attention deficit hyperactivity disorder.
    Vitiello B
    J Child Adolesc Psychopharmacol; 2001; 11(1):25-34. PubMed ID: 11322742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.
    Merkel RL
    Expert Opin Drug Saf; 2010 Nov; 9(6):917-35. PubMed ID: 20615078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth deficits in children with attention deficit hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Pediatrics; 1998 Aug; 102(2 Pt 3):501-6. PubMed ID: 9685453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.